ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1357

Clinical Description of Patients with Cytoplasmic Discrete Speckles on Indirect Immunofluorescence on HEp-2 Cells in a Universitary Hospital

Martin Brom1, Carolina Eva Carrizo2, Roberto Arana3 and Cecilia N. Pisoni3, 1Hospital Italiano de Buenos Aires, Buenos Aires, Argentina, 2CEMIC, Buenos Aires, Argentina, 3Rheumatology and Immunology, CEMIC, Buenos Aires, Argentina

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Clinical, laboratory tests and observation

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 14, 2016

Title: Miscellaneous Rheumatic and Inflammatory Diseases - Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Indirect Immunofluorescence (IIF) shows different nuclear and cytoplasmic fluorescence patterns depending on the antibodies present in the cell. Cytoplasmic patterns are an unusual finding. Their study is not standardized and their clinical value is unknown. The Cytoplasmic Discrete Speckles (CDS) pattern comprises several antigens distributed in the endosomes, lysosomes and GW bodies. The purpose of this study is to describe demographic and clinical characteristics of patients with CDS pattern on IIF in a cohort of patients.

Methods: This is a retrospective descriptive study. We included all patients with a CDS pattern on IIF on HEp-2 cells with a titer equal or greater than 1/80, using a database of all IIF performed in a referral laboratory of a universitary hospital between 2007 and 2015.

We analyzed demographical and clinical information available on their clinical records. We included sex, age, health history and symptoms compatible with autoimmune diseases.

Results: In that period of time, 7085 IIF studies were performed and 21 patients showed CDS pattern (0.29%). We reviewed 17 out of 21 clinical records. We excluded 4 patients that did not have clinical records at the hospital. All patients were female, with a median age of 62 (range 50-81 years). Demographics and clinical characteristics are shown in table 1. We found no relationship between the IIF titer, health history and symptoms compatible with autoimmune diseases. Fourteen of the patients (82%) had at least one symptom of autoimmune disease. Eight of the patients (47%) had an autoimmune disease, being Hashimoto Thyroiditis the most frequent one (50%).

A high rate of respiratory symptoms was observed among these patients. Six of them (34%) referred dyspnea and dry cough. They had different underlying causes, including chronic obstructive pulmonary disease (COPD). Symptoms description is shown in table 2.

Conclusion: CDS pattern is uncommon. We found no association with any particular disease, and none of our patients had any of the diseases described in other studies. Taking into account the low prevalence of this pattern and the heterogeneity of symptoms, the study of antibodies underlying this IIF pattern seems more useful for cell biology study than for clinical use.


Disclosure: M. Brom, None; C. E. Carrizo, None; R. Arana, None; C. N. Pisoni, None.

To cite this abstract in AMA style:

Brom M, Carrizo CE, Arana R, Pisoni CN. Clinical Description of Patients with Cytoplasmic Discrete Speckles on Indirect Immunofluorescence on HEp-2 Cells in a Universitary Hospital [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/clinical-description-of-patients-with-cytoplasmic-discrete-speckles-on-indirect-immunofluorescence-on-hep-2-cells-in-a-universitary-hospital/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/clinical-description-of-patients-with-cytoplasmic-discrete-speckles-on-indirect-immunofluorescence-on-hep-2-cells-in-a-universitary-hospital/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology